Cited by 70Attention Deficit Hyperactivity DisorderSleep and related disordersCircadian rhythm and melatonin

Actigraphic Monitoring During Sleep of Children With ADHD on Methylphenidate and Placebo

SCHWARTZ, GEORGE, AMOR, LEILA BEN, GRIZENKO, NATALIE, LAGEIX, PHILIPPE, BARON, CHANTAL, BOIVIN, DIANE B., JOOBER, RIDHA·2004·Journal of the American Academy of Child & Adolescent Psychiatry

Abstract

Objective Sleep disturbances appear as a comorbid condition in children with attention-deficit/hyperactivity disorder. The aim of this study was to investigate the relationship of activity levels during sleep and therapeutic response to methylphenidate (MPH).Method Nightly sleep actigraphic recordings during a double-blind, placebo-controlled, crossover clinical study (1-week of 0.5 mg/kg MPH; 1-week of placebo) were obtained on 44 children, 6 to 12 years old, diagnosed with attention-deficit/hyperactivity disorder (DSM-IV).Results Significant (p <.005) differences between the conditions were found in several software-computed parameters: sleep onset latency (MPH, 39.3 minutes; placebo, 28.2 minutes), sleep efficiency (MPH, 78.0%; placebo, 80.4%), total sleep time (MPH, 7 hours; 57 minutes; placebo, 8 hours, 16 minutes). No significant differences on any of these measures were found among the 26 subjects who showed a moderate or large global improvement on MPH over placebo compared with 18 subjects who showed mild or no clinical improvement.Conclusions MPH, given twice daily, induces a slight but significant sleep disturbance. Motor activity levels during sleep did not differentiate children who responded to MPH from those who did not respond. This suggests that responders to MPH treatment do not experience greater sleep disturbances than nonresponders, at least at the dose studied.

Integrity signals

Registry

Crossref · 10.1097/01.chi.0000135802.94090.93

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In a placebo-controlled cross-over actigraphic monitoring study of 44 children, sleep latency was similar in children with ADHD on methylphenidate versus placebo, but total sleep duration was shorter with methylphenidate than placebo.

    “In a placebo-controlled cross-over actigraphic monitoring study of 44 children, sleep latency was similar in children with ADHD on methylphenidate versus placebo, but total sleep duration was shorter with methylphenidate than placebo [125].”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
SCHWARTZ, G., AMOR, L. B., GRIZENKO, N., LAGEIX, P., BARON, C., BOIVIN, D. B., & JOOBER, R.
Affiliations
Douglas Mental Health University Institute (CA)
Corresponding author
JOOBER, RIDHA
Venue
Journal of the American Academy of Child & Adolescent Psychiatry
Publisher
Elsevier BV
Published
2004-10
Volume
43
Issue
10
Pages
1276-1282
ISSN
0890-8567 (ISSN-L)
OpenAlex
W2090634557
Cited by
70
References
41
Citations by year
2026: 1 · 2025: 2 · 2023: 1 · 2022: 2 · 2021: 1 · 2020: 2 · 2018: 3 · 2017: 3 · 2016: 1 · 2015: 4 · 2014: 1 · 2013: 5 · 2012: 6
FWCI
2.92
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of the American Academy of Child & Adolescent Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Circadian rhythm and melatonin
Keywords
attention deficit hyperactivity disorder, methylphenidate, sleep disorders, actigraphy, sleep latency, sleep efficiency, total sleep time, treatment response, children
MeSH terms
Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Child, Data Collection, Double-Blind Method, Female, Humans, Male, Methylphenidate, Movement, Placebos, Sleep Wake Disorders, Cross-Over Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review